RedHill Biopharma Short Interest Ratio and Short Volume

+0.18 (+3.79 %)
(As of 09/23/2021 02:35 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume24,427 shs
Average Volume561,053 shs
Market Capitalization$230.07 million
P/E RatioN/A
Dividend YieldN/A

RedHill Biopharma (NASDAQ:RDHL) Short Interest Data

Current Short Volume1,850,000 shares
Previous Short Volume2,030,000 shares
Change Vs. Previous Month-8.87%
Dollar Volume Sold Short$18.69 million
Short Interest Ratio / Days to Cover3.1
Last Record DateAugust, 31 2021
Outstanding Shares46,667,000 shares
Float Size45,750,000 shares
Short Percent of Float4.04%
Today's Trading Volume24,427 shares
Average Trading Volume561,053 shares
Today's Volume Vs. Average-95.65%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling RedHill Biopharma ?

Sign up to receive the latest short interest report for RedHill Biopharma and its competitors with MarketBeat's FREE newsletter.

RedHill Biopharma (NASDAQ:RDHL) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20211,850,000 shares $18.69 million -8.9%4.0%3.1 $10.10
8/13/20212,030,000 shares $14.41 million +21.6%4.4%6.7 $7.10
7/30/20211,670,000 shares $10.75 million -19.3%3.7%5.8 $6.44
7/15/20212,070,000 shares $12.36 million +10.1%N/A7.6 $5.97
6/30/20211,880,000 shares $12.93 million +2.7%N/A7.4 $6.88
6/15/20211,830,000 shares $13.12 million -7.6%N/A6.8 $7.17
5/28/20211,980,000 shares $14.36 million -14.7%N/A6.9 $7.25
5/14/20212,320,000 shares $13.87 million +17.8%N/A6.8 $5.98
4/30/20211,970,000 shares $13.73 million -2.0%N/A4.8 $6.97
4/15/20212,010,000 shares $14.23 million -27.2%N/A3.7 $7.08
3/31/20212,760,000 shares $19.73 million +8.7%N/A4.7 $7.15
3/15/20212,540,000 shares $20.07 million +5.4%N/A4.3 $7.90
2/26/20212,410,000 shares $23.96 million No ChangeN/A4.2 $9.94
2/12/20212,410,000 shares $22.75 million -5.9%N/A4.8 $9.44
1/29/20212,560,000 shares $22.58 million +8.9%N/A5.7 $8.82
1/15/20212,350,000 shares $17.32 million -2.5%N/A5.9 $7.37
12/31/20202,410,000 shares $20.63 million +23.6%N/A7.6 $8.56
12/15/20201,950,000 shares $16.58 million +2.1%N/A7.3 $8.50
11/30/20201,910,000 shares $16.90 million +21.7%N/A6.1 $8.85
11/15/20201,570,000 shares $12.86 million -11.8%N/A4.7 $8.19
10/30/20201,780,000 shares $15.56 million +8.5%N/A5.4 $8.74
10/15/20201,640,000 shares $16.53 million +3.1%N/A4.1 $10.08
9/30/20201,590,000 shares $16.25 million -20.5%N/A4 $10.22
9/15/20202,000,000 shares $21.52 million +1.0%59.9%4.7 $10.76
8/31/20201,980,000 shares $16.35 million -4.4%59.3%5 $8.26

Institutional Investors Shorting RedHill Biopharma (NASDAQ:RDHL)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of RedHill Biopharma. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
8/17/2021Citadel Advisors LLC167,200178,700+6.9%$1,229.00
8/12/2021Simplex Trading LLCN/A15,000N/A$103.00
8/11/2021Susquehanna International Group LLP239,300167,100-30.2%$1,150.00
7/31/2021Cutler Group LP4000-100.0%$0.00

RedHill Biopharma (NASDAQ:RDHL) Short Interest FAQ

speech bubbles
speech bubbles

RedHill Biopharma (NASDAQ:RDHL) Short Interest Frequently Asked Questions

What is RedHill Biopharma's current short interest?

Short interest is the volume of RedHill Biopharma shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 1,850,000 shares of RDHL short. 4.04% of RedHill Biopharma's shares are currently sold short. Learn More on RedHill Biopharma's current short interest.

What is a good short interest ratio for RedHill Biopharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RedHill Biopharma currently has a short interest ratio of 3.0. Learn More on a good short interest ratio for RedHill Biopharma

Which institutional investors are shorting RedHill Biopharma?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of RedHill Biopharma: Citadel Advisors LLC, Simplex Trading LLC, Susquehanna International Group LLP, and Cutler Group LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for RedHill Biopharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.04% of RedHill Biopharma's floating shares are currently sold short.

Is RedHill Biopharma's short interest increasing or decreasing?

RedHill Biopharma saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 1,850,000 shares, a drop of 8.9% from the previous total of 2,030,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is RedHill Biopharma's float size?

RedHill Biopharma currently has issued a total of 46,667,000 shares. Some of RedHill Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RedHill Biopharma currently has a public float of 45,750,000 shares.

How does RedHill Biopharma's short interest compare to its competitors?

4.04% of RedHill Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to RedHill Biopharma: Syndax Pharmaceuticals, Inc. (19.15%), Avidity Biosciences, Inc. (0.00%), Edgewise Therapeutics, Inc. (8.99%), Amphastar Pharmaceuticals, Inc. (6.91%), Dyne Therapeutics, Inc. (5.44%), Merus (7.41%), Phibro Animal Health Co. (6.08%), BioXcel Therapeutics, Inc. (10.79%), Praxis Precision Medicines, Inc. (3.37%), and Zogenix, Inc. (13.67%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short RedHill Biopharma stock?

Short selling RDHL is an investing strategy that aims to generate trading profit from RedHill Biopharma as its price is falling. RedHill Biopharma's stock is trading up $0.18 today. To short RedHill Biopharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that RedHill Biopharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against RedHill Biopharma?

A short squeeze for RedHill Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RDHL, which in turn drives the price of the stock up even further.

How often is RedHill Biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDHL, twice per month. The most recent reporting period available is August, 31 2021.

This page was last updated on 9/23/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.